BIOCENTECH APS: Financial statements 2023
CVR: 25437470
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIOCENTECH APS (CVR 25437470) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -14,792 and a net result of DKK -16,380 compared with DKK -6,314 the year before. Equity in the 2023 report amounted to DKK -27,273.
- Gross Profit
- DKK -14,792
- Profit/Loss
- DKK -16,380
- Equity
- DKK -27,273
- Total Assets
- DKK 77,315
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -15 t. | -16 t. | -27 t. | - |
| 2022 | - | -5 t. | -6 t. | 3 t. | - |
| 2021 | - | -6 t. | -7 t. | 9 t. | - |
| 2020 | - | -6 t. | -7 t. | 17 t. | - |
| 2019 | - | -5 t. | -5 t. | 24 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BIOCENTECH APS has published its interim report for the period October 1, 2022 – December 31, 2022.
BIOCENTECH APS has published its annual report for 2022. Gross profit came to DKK -5,000, and the net result was DKK -6,314.
About BIOCENTECH APS
BIOCENTECH APS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Aleksander Nærvig. The company is owned by NÆRVIG GROUP ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,000 and a net result of DKK -14,669 compared with DKK -19,363 the year before. Equity in the 2025 report amounted to DKK -61,305.